Presentations :
Bridging studies – why and how?
Peter Dull, Bill & Melinda Gates Foundation.
Criteria and requirement for the licensing of new vaccines with special emphasis on COVID-19 the view of EMA.
Marco Cavaleri, Head of Office Biological Health Threats and Vaccine Strategy, European Medicines Agency.
HPV Vaccination: The evidence in favour of a one and only dose schedule and its limitations. Presenter: Margaret Stanley, University of Cambridge, UK
COVID-19 Vaccine Safety – Perspective from WHO’s Global Advisory Committee on Vaccine Safety : Presenter: Rita Helfand. COVID-19 Vaccine Safety – US experience : Presenter: Tom Shimabukuro,
There will be two main presentations as follows: The Immunological benefits of mRNA and potential applications - Presenter: Barney Graham, previously with the National Institute of Health, USA. Regulatory approaches: Issues and challenges, and questions to be asked by regulators - Presenter: Philip Krause, Food & Drug Administration, USA.
- Vacunas contra el COVID: ¿Hay necesidad de refuerzos en vista de la aparición de nuevas variantes y la disminución de la inmunidad? S4
- COVID vaccines – is there a need for boosters in view of the emergence of variants and waning immunity? S3
- Vaccins COVID - est-il nécessaire de procéder à des rappels compte tenu de l'émergence de variants et de la baisse de l'immunité dans le temps? S2
- COVID vaccines – is there a need for boosters in view of the emergence of variants and waning immunity? S1